The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Hägg, David ^a   Eriksson, Marie ^b   Sundström, Anders ^c   Schmitt Egenolf, Marcus ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; COHORT ANALYSIS; DISEASE SEVERITY; DRUG USE; FEMALE; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PSORIATIC ARTHRITIS; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SEX RATIO;

ADULT; AGED; BIOLOGICAL PRODUCTS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PSORIASIS; SEVERITY OF ILLNESS INDEX; SWEDEN;

EID: 84877774022     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063619     Document Type: Article

References (19)

1. Ena P, Madeddu P, Glorioso N, Cerimele D, Rappelli A, (1985) High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. Acta Cardiol 40: 199-205.
2. Mallbris L, Akre O, Granath F, Yin L, Lindelof B, et al. (2004) Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 19: 225-230.
3. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, et al. (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296: 1735-1741.
4. Lin HW, Wang KH, Lin HC, Lin HC, (2011) Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan. J Am Acad Dermatol 64: 495-501.
5. Lomholt G, (1964) Prevalence of Skin Diseases in a Population; a Census Study from the Faroe Islands. Dan Med Bull 11: 1-7.
6. Farber EM, Peterson JB, (1961) Variations in the natural history of psoriasis. Calif Med 95: 6-11.
7. Rustin MH, (2012) Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data. Br J Dermatol 167Suppl 3: 3-11.
8. Ragnarson Tennvall G, Hjortsberg C, Bjarnason A, Gniadecki R, Heikkila H, et al. (2012) Treatment Patterns, Treatment Satisfaction, Severity of Disease Problems, and Quality of Life in Patients with Psoriasis in Three Nordic Countries. Acta Derm Venereol.
9. Schmitt-Egenolf M, (2007) PsoReg-the Swedish registry for systemic psoriasis treatment. The registry's design and objectives. Dermatology 214: 112-117.
10. Ormerod AD, Augustin M, Baker C, Chosidow O, Cohen AD, et al. (2012) Challenges for synthesising data in a network of registries for systemic psoriasis therapies. Dermatology 224: 236-243.
11. Arkema EV, Neovius M, Joelsson JK, Simard JF, van Vollenhoven RF, (2012) Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study. Ann Rheum Dis 71: 1203-1206.
12. Hotard RS, Feldman SR, Fleischer AB Jr, (2000) Sex-specific differences in the treatment of severe psoriasis. J Am Acad Dermatol 42: 620-623.
13. Nyberg F, Osika I, Evengard B, (2008) "The Laundry Bag Project"-unequal distribution of dermatological healthcare resources for male and female psoriatic patients in Sweden. Int J Dermatol 47: 144-149.
14. White D, O'Shea SJ, Rogers S, (2012) Do men have more severe psoriasis than women? J Eur Acad Dermatol Venereol 26: 126-127.
15. Feldman SR, Krueger GG (2005) Psoriasis assessment tools in clinical trials. Ann Rheum Dis 64 Suppl 2: ii65-68; discussion ii69-73.
16. Schafer I, Hacker J, Rustenbach SJ, Radtke M, Franzke N, et al. (2010) Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment. Eur J Dermatol 20: 62-67.
17. Langley RG, Ellis CN, (2004) Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol 51: 563-569.
18. Traupe H, van Gurp PJ, Happle R, Boezeman J, van de Kerkhof PC, (1992) Psoriasis vulgaris, fetal growth, and genomic imprinting. Am J Med Genet 42: 649-654.
19. Fish EN, (2008) The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 8: 737-744.